Adding the p16INK4a Marker to the Traditional 3-marker (ER/Vim/CEA) Panel Engenders No Supplemental Benefit in Distinguishing Between Primary Endocervical and Endometrial Adenocarcinomas in a Tissue Microarray Study
- 1 September 2009
- journal article
- pathology of-the-lower-genital-tract
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 28 (5) , 489-496
Abstract
Endocervical adenocarcinomas (ECAs) and endometrial adenocarcinomas (EMAs) are malignancies that affect the uterus; however, their biologic behaviors are quite different. This distinction has clinical significance, because the appropriate therapy may depend on the site of tumor origin. In this study, we not only compare the individual expression status of 4 immunomarkers [estrogen receptor (ER), vimentin (Vim), carcinoembryonic antigen (CEA), and p16INK4a], but also evaluate whether p16INK4a adds value to the ER/Vim/CEA panel characteristics and performance in distinguishing between primary ECA and EMA. A tissue microarray (TMA) was constructed using paraffin-embedded, formalin-fixed tissues from 38 hysterectomy specimens, including 14 ECAs and 24 EMAs. Tissue microarray sections were immunostained with 4 antibodies, by the avidin-biotin complex method for antigen visualization. The staining intensity and area extent of the immunohistochemical reactions were evaluated using the semiquantitative scoring system. The 3 markers (ER, Vim, CEA) and their respective panel expressions showed statistically significant (PINK4a marker also revealed a significant frequency difference (PINK4a-marker testing does not add value to the 3-marker panel in distinguishing between primary ECA and EMA.Keywords
This publication has 29 references indexed in Scilit:
- Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localizationJournal of Experimental & Clinical Cancer Research, 2008
- Translational medicine: science or wishful thinking?Journal of Translational Medicine, 2008
- A Life in Passing: Jonathan GrayJournal of Translational Medicine, 2007
- Variance in multiplex suspension array assays: carryover of microspheres between sample wellsJournal of Negative Results in BioMedicine, 2007
- Independent prognostic significance of cell cycle regulator proteins p16INK4a and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study GroupBritish Journal of Cancer, 2007
- Immunohistochemical Expression of p16INK4A, Ki-67, and Mcm2 Proteins in Gastrointestinal Stromal Tumors: Prognostic Implications and Correlations with Risk Stratification of NIH Consensus CriteriaAnnals of Surgical Oncology, 2006
- Immunohistochemical detection of p16INK4a in dysplastic lesions of the oral cavityLaboratory Investigation, 2006
- Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosisLaboratory Investigation, 2006
- PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to ImatinibJournal of Clinical Oncology, 2005
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978